Insights Into Amicus Therapeutics (FOLD) Q4: Wall Street Projections for Key Metrics

Wall Street analysts forecast that Amicus Therapeutics (FOLD) will report quarterly earnings of $0.10 per share in its upcoming release, pointing to a year-over-year increase of 190.9%. It is anticipated that revenues will amount to$ 149.53 million, exhibiting an increase of 29.9% compared to the year-ago quarter.The current level reflects a downward revision of 80% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively re ...